5 Key Takeaways

• 1

  Metformin may reduce the incidence of posterior capsule opacification (PCO), a common complication after cataract surgery.

• 2

  A study found that metformin accumulates in the human lens capsule, correlating with serum concentrations in patients.

• 3

  In vitro assays demonstrated that metformin significantly attenuates lens epithelial cell proliferation compared to controls.

• 4

  The findings suggest that metformin use may modify PCO risk, challenging previous epidemiological data on diabetes and PCO.

• 5

  The authors advocate for larger studies to explore metformin as a potential adjunct treatment for preventing PCO.